{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:43:07Z","timestamp":1762101787700},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ504","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:33:10Z","timestamp":1447115590000},"page":"S554-S562","source":"Crossref","is-referenced-by-count":8,"title":["Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays"],"prefix":"10.1093","volume":"61","author":[{"given":"Gregory A.","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee M.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Plikaytis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Mocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Carlone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samba O.","family":"Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldiouma","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olubukola T.","family":"Idoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin C.","family":"Enwere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Elie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret C.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"issue":"suppl","key":"key\n\t\t\t\t20171014003050_CIV504C1","first-page":"1","article-title":"Cerebrospinal meningitis in Africa [in French]","volume":"28","year":"1963","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20171014003050_CIV504C2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","year":"1977","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014003050_CIV504C3","first-page":"1","article-title":"Cerebrospinal meningitis control. Report of a WHO study group","author":"World Health Organization","year":"1976","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"suppl 1","key":"key\n\t\t\t\t20171014003050_CIV504C4","first-page":"A97","article-title":"The Meningitis Vaccine Project","volume":"25","year":"2007","journal-title":"Vaccine"},{"issue":"(suppl 5)","key":"key\n\t\t\t\t20171014003050_CIV504C5","first-page":"S434","article-title":"Introduction and rollout of a new group A meningococcal conjugate vaccine (PsA-TT) in African meningitis belt countries, 2010--2014","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014003050_CIV504C6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/3527608508.ch16","article-title":"Surrogates of protection","volume-title":"Handbook of meningococcal disease","year":"2006"},{"key":"key\n\t\t\t\t20171014003050_CIV504C7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","year":"1969","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171014003050_CIV504C8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","year":"1969","journal-title":"J Exp Med"},{"issue":"suppl 2","key":"key\n\t\t\t\t20171014003050_CIV504C9","first-page":"B112","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","year":"2009","journal-title":"Vaccine"},{"issue":"suppl 1","key":"key\n\t\t\t\t20171014003050_CIV504C10","first-page":"S58","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003050_CIV504C11","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2012.08.004","article-title":"Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2\u201310 years: a phase II\/III double-blind randomized controlled trial","volume":"30","year":"2012","journal-title":"Vaccine"},{"issue":"suppl 1","key":"key\n\t\t\t\t20171014003050_CIV504C12","first-page":"A101","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003050_CIV504C13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","year":"2009","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014003050_CIV504C14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vaccine.2011.10.068","article-title":"Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source","volume":"30","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003050_CIV504C15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20171014003050_CIV504C16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/CVI.00812-13","article-title":"Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers","volume":"21","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20171014003050_CIV504C17","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014003050_CIV504C18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20171014003050_CIV504C19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/JCM.30.1.154-159.1992","article-title":"Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay","volume":"30","year":"1992","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014003050_CIV504C20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992","volume":"2","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20171014003050_CIV504C21","doi-asserted-by":"crossref","first-page":"e55486","DOI":"10.1371\/journal.pone.0055486","article-title":"Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171014003050_CIV504C22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-4453(88)96117-8","article-title":"Meningococcal carriage, meningococcal disease and vaccination","volume":"16","year":"1988","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20171014003050_CIV504C23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(07)70288-8","article-title":"Meningococcal carriage in the African meningitis belt","volume":"7","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171014003050_CIV504C24","first-page":"40","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]","volume":"383","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014003050_CIV504C25","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pmed.0040101","article-title":"Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana","volume":"4","year":"2007","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171014003050_CIV504C26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12325-013-0032-5","article-title":"Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT","volume":"30","year":"2013","journal-title":"Adv Ther"},{"key":"key\n\t\t\t\t20171014003050_CIV504C27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2334-13-116","article-title":"Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study","volume":"13","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171014003050_CIV504C28","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4161\/hv.22166","article-title":"Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers","volume":"8","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20171014003050_CIV504C29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","year":"1983","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014003050_CIV504C30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CVI.00008-07","article-title":"Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7","volume":"14","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20171014003050_CIV504C31","first-page":"883","article-title":"Effect of group-A meningococcal vaccine in army recruits in Finland","volume":"2","year":"1975","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014003050_CIV504C32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2004.07.042","article-title":"Naturally-acquired immunity to Neisseria meningitidis group A","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003050_CIV504C33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.inf.0000135659.52662.a2","article-title":"Serum group a anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic","volume":"23","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171014003050_CIV504C34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/infdis\/166.2.359","article-title":"Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya\/Centers for Disease Control (CDC) Meningitis Study Group","volume":"166","year":"1992","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003050_CIV504C35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12879-014-0663-4","article-title":"Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac","volume":"14","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171014003050_CIV504C36","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1365-3156.2007.01929.x","article-title":"Systematic review: impact of meningococcal vaccination on pharyngeal carriage of meningococci","volume":"12","year":"2007","journal-title":"Trop Med Int Health"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S554\/20914001\/civ504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T04:40:50Z","timestamp":1599799250000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S554\/417715\/Human-Complement-Bactericidal-Responses-to-a-Group"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":36,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ504","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}